2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

  1. Landmesser, U.
  2. Chapman, M.J.
  3. Stock, J.K.
  4. Amarenco, P.
  5. Belch, J.J.F.
  6. Borén, J.
  7. Farnier, M.
  8. Ference, B.A.
  9. Gielen, S.
  10. Graham, I.
  11. Grobbee, D.E.
  12. Hovingh, G.K.
  13. Lüscher, T.F.
  14. Piepoli, M.F.
  15. Ray, K.K.
  16. Stroes, E.S.
  17. Wiklund, O.
  18. Windecker, S.
  19. Zamorano, J.L.
  20. Pinto, F.
  21. Tokgözoǧlu, L.
  22. Bax, J.J.
  23. Catapano, A.L.
Revue:
European Heart Journal

ISSN: 1522-9645,  0195-668X

Année de publication: 2018

Volumen: 39

Número: 14

Pages: 1131-1143

Type: Révision

DOI: 10.1093/EURHEARTJ/EHX549 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus